findmyKOL

Morton Coleman, MD

Basic profile

Cornell University

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyHematology / OncologyFocusOncology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Morton Coleman is an Oncology physician affiliated with Cornell University. OpenAlex indexes 430 publications with 15,298 citations (h-index 57). By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
430publications

Distinct works indexed by OpenAlex, matched via ORCID.

15,298citations

Total citations across indexed works.

57h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

407 E 70th St
3rd Floor
New York, NY 100215302

Telephone

212-517-5900

Registry record last updated 13 Jun 2008.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    34.2%
    Statin34.2%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Musculoskeletal

    26.3%
    Xanthine oxidase inhibitor26.3%
    Allopurinol100%
    Part D<11 patients
  • Anti-infectives

    22.4%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor22.4%
    Valacyclovir100%
    Part D<11 patients
Where care is delivered (Part B), 20200% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”